Nifedipine and Phenobarbital, hyoscyamine, atropine, and scopolamine interaction

Nifedipine and Phenobarbital, hyoscyamine, atropine, and scopolamine: the Nifedipine prescribing label describes an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Nifedipine label · effective 2026-02-05

Moderate

Alternative antihypertensive therapy should be considered in patients taking phenytoin, phenobarbital, and carbamazepine.

Precautionsnames Phenobarbital, hyoscyamine, atropine, and scopolamineView label on DailyMed
Minor

Strong CYP3A Inducers Strong CYP3A inducers, such as rifampin, rifabutin, phenobarbital, phenytoin, carbamazepine, and St.

Drug interactionsnames Phenobarbital, hyoscyamine, atropine, and scopolamineView label on DailyMed
Minor

Phenytoin, Phenobarbital, and Carbamazepine: Nifedipine is metabolized by CYP3A.

Precautionsnames Phenobarbital, hyoscyamine, atropine, and scopolamineView label on DailyMed
Minor

Phenobarbital and carbamazepine are also inducers of CYP3A.

Precautionsnames Phenobarbital, hyoscyamine, atropine, and scopolamineView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.